Γ

SynBioBeta Speaker

Gloria Elliot

ARPA-H

PM, Scalable Solutions

Dr. Gloria Elliott joined ARPA-H in January 2025 from the Organ Preservation Alliance where she served as president and Chief Science Officer. Prior to that, Elliott was the founding Chief Science Officer of Humanity Bio, a small biotechnology research company focused on human tissue preservation.Elliott is a professor emerita at the University of North Carolina at Charlotte. Her expertise is in cryobiology and biopreservation technology, especially non-refrigerated methods. She received her doctorate in mechanical engineering from Michigan State University and completed post-doctoral work at Harvard Medical School and the Massachusetts General Hospital Center for Engineering in Medicine.

Sessions Featuring

Gloria

This Year

12:00 AM

-

12:00 AM

Inside ARPA-H: Bold Bets That Could Redefine Human Health

ARPA-H Program Managers are charting some of the most ambitious trajectories in biomedical innovation — from tissue regeneration and whole-body replacement strategies to ultra-scalable manufacturing, programmable immunity, cognitive resilience, and next-generation diagnostics. In this high-velocity block of lightning talks and roundtable, PMs will unveil the problems they’re trying to solve, the technical leaps they believe are now possible, and the kinds of audacious proposals they want from the community. It’s a rare, fast-paced look into the “high-risk, high-reward” experiments that could shift the boundaries of what medicine can do.

12:00 AM

-

12:00 AM

Inside ARPA-H: Bold Bets That Could Redefine Human Health

ARPA-H Program Managers are charting some of the most ambitious trajectories in biomedical innovation — from tissue regeneration and whole-body replacement strategies to ultra-scalable manufacturing, programmable immunity, cognitive resilience, and next-generation diagnostics. In this high-velocity block of lightning talks and roundtable, PMs will unveil the problems they’re trying to solve, the technical leaps they believe are now possible, and the kinds of audacious proposals they want from the community. It’s a rare, fast-paced look into the “high-risk, high-reward” experiments that could shift the boundaries of what medicine can do.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include